Analyst Conference Summaries

Biotechnology Investor Aids

Illumina
ILMN

conference date: November 4, 2024 @ 1:30 PM Pacific Time

Illumina Remains a Sell After 2023 Guidance [January 11, 2023]

Illumina Needs Grail, But May Lose It [August 29, 2022]

Illumina: 2021 Revenue Should Be Better Than 2020 [May 12, 2020]

2023
Illumina
ILMN
Q4 2023
Illumina
ILMN
Q1 2024
Illumina
ILMN
Q2 2024
Illumina
ILMN
Q3 2024
Feb. 8, 2024 May 2, 2024 Aug. 6, 2024 Nov. 4, 2024
2023
Illumina
ILMN
Q4 2022
Illumina
ILMN
Q1 2023
Illumina
ILMN
Q2 2023
Illumina
ILMN
Q3 2023
Feb. 7, 2023 April 25, 2023 Aug. 9, 2023 Nov. 9, 2023
2022
Illumina
ILMN
Q4 2021
Illumina
ILMN
Q1 2022
Illumina
ILMN
Q2 2022
Illumina
ILMN
Q3 2022
Feb. 10, 2022 May 5, 2022 Aug. 11, 2022 Nov. 3, 2022
2021
Illumina
ILMN
Q4 2020
Illumina
ILMN
Q1 2021
Illumina
ILMN
Q2 2021
Illumina
ILMN
Q3 2021
Feb. 11, 2021 April 27, 2021 August 5, 2021 Nov. 4, 2021
2020
Illumina
ILMN
Q4 2019
Illumina
ILMN
Q1 2020
Illumina
ILMN
Q2 2020
Illumina
ILMN
Q3 2020
Jan. 29, 2020 April 30, 2020 Aug. 6, 2020 Oct. 29, 2020
2019
Illumina
ILMN
Q4 2018
Illumina
ILMN
Q1 2019
Illumina
ILMN
Q2 2019
Illumina
ILMN
Q3 2019
Jan. 29, 2019 April 25, 2019 July 29, 2019 Oct. 24, 2019
2018
Jan. 30, 2018
April 24, 2018
July 30, 2018
Oct. 23, 2018
2017
01/31/2017
April 25, 2017
August 1, 2017
Oct. 24, 2016
2016
02/02/2016
05/03/2016
07/26/2016
11/01/2016
2015
01/27/2015
04/21/2015
07/21/2015
10/20/2015
2014
01/28/2014
04/28/2014
07/23/2014
10/20/2014

Illumina: Missed March Opportunity, Good Long-Term Prospects [May 12, 2020]

Illumina A Long-Term Buy, With Caveats [September 16, 2019]

Illumina Preliminary Q3 Revenue [Oct. 5, 2015 press release]

Illumina Sequences Profits, Exceeding Q3 Guidance [Oct. 22, 2014]

Illumina Sequences Profits, Exceeding Q3 Guidance [Oct. 22, 2014]

Illumina (ILMN) is a manufacturer of DNA sequencing equipment.

Illumina web site
Illumina investor relations page


Analyst Conferences main page

Search

More Analyst Conference Pages:

 AGEN
 AGIO
 ALLO
 ALNY
 AMAT
 AMGN
 BIIB
 BLRX
 BLUE
 BMY
 CDTX
 CLDX
 FATE
 GILD
 GLYC
 ILMN
 INO
 INCY
 ISRG
 MCHP
 MRNA
 PLX
 REGN
 RNA
 SAGE
 SANA
 SYRS
 TSVT
 VRTX
 VSTM
 WBA

 
 

Disclaimer: Our analyst summaries may include both our condensations of statements made by company representatives and our own analysis. They are not covered by any warranty. We cannot guarantee anything said by company representatives is true. We try not to make errors, but it is possible. Before making or terminating an investment you should always verify any factual basis of your decision.

Copyright 2024 William P. Meyers